CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: A Study of Semagacestat for Alzheimer's Patients [Phase 3]
Summary
Phase 3 trial of semagacestat for Alzheimer's disease completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-09-25